Data security business Cyera is set to be valued at $6 billion in a new investment round, according to people with knowledge of the matter.

Cytokinetics (CYTK) announced that additional data arising from two analyses from SEQUOIA-HCM, the pivotal Phase 3 clinical trial of aficamten in ...